In a mouse model of loss-of-function mutations of PRC2 resulting in RAS pathway hyperactivation, tumor growth of peripheral nerve sheath tumors was observed when coupled with another mutation, for example, of NF1. The tumor was sensitive to a BET protein inhibitor in that study (109). This evidence concerns the gene NF1 and neoplasm.